The finding gives scientists a path to understand diseases where frequent blood-brain barrier damage occurs, including traumatic brain injury, stroke, epilepsy, Alzheimer’s disease, and Parkinson’s disease.
The National Institute on Drug Abuse recently awarded a $2.6 million grant to researchers at East Tennessee State University and Virginia Tech to develop studies on how best to provide peer support services for individuals being treated for opioid use disorder.
Starting this week, as students begin to return to campus for the fall semester, the lab’s capacity of 1,000 tests per day will also be dedicated to Virginia Tech students and employees in high-contact roles.
Fralin Biomedical Research Institute scientists have revealed how a nonfunctioning version of an ordinary gene impairs brain structure and function. The findings help explain a genetic form of microcephaly — a condition where babies’ heads are small and grow more slowly than their peers' heads.
Research partners across three institutions are opening the nation’s first and only resource center, known as C-PROGRESS, dedicated to promoting clinical trials research in the rapidly expanding field of pediatric rehabilitation.
Supported by a new, five-year, $2.8 million National Institutes of Health grant awarded to Harald Sontheimer, a glial neurobiologist at the Fralin Biomedical Research Institute at VTC, scientists are probing changes caused by aging in the circulatory system in the normal brain and Alzheimer’s disease brain.
Finkielstein, a molecular biologist and an associate professor in the College of Science, will join the Fralin Biomedical Research Institute at VTC on July 1. Her laboratory, which studies how circadian rhythms are involved in breast cancer progression, will move to the Health Sciences and Technology Campus in Roanoke.
Using CRISPR genome editing in zebrafish, scientists with the Fralin Biomedical Research Institute at VTC linked an undiagnosed human disease with a rare genetic mutation that causes craniofacial abnormalities.
New ways to help people resist the siren call of alcohol have not kept pace — which leaves health care providers stuck with the same intervention and rehabilitation options they have been using for decades. But now, Virginia Tech scientists are studying whether people battling alcohol use disorder might gain some relief by “pre-experiencing” the future.
An international research team comprising neuroscientists at Virginia Tech and the University of London revealed brain mechanisms and functional regions that underlie confirmation bias — a phenomenon where people strongly favor information that reinforces their existing opinions over contradictory ones.
With a focus on health sciences and technology, the HS&T Hokie Pitch will involve 30 students who have worked with real-world mentors, selected intellectual property, and created an entrepreneurial plan to develop and commercialize biomedical discoveries.
Elected by their peers and representing a broad range of AAAS “sections,” including statistics, neuroscience, engineering, psychology, and geology/geography, the Virginia Tech professors are among 443 newly elected scholars.
The campus is an expansion of Children’s National that is located on a nearly 12-acre portion of the former Walter Reed Army Medical Center in Washington, D.C., and is set to open its first phase in December 2020.
Michael J. Friedlander, the vice president for health sciences at Virginia Tech and executive director of the Fralin Biomedical Research Institute at VTC, will aid Children’s National efforts to improve understanding of the prevention, treatment, and care of childhood diseases.
Virginia Tech President Tim Sands and Carilion Clinic’s President and Chief Executive Officer Nancy Howell Agee set the tone for the meeting by portraying how both organizations have invested significantly throughout the region and across the commonwealth.